A revolutionary mRNA-based vaccine has proven effective in preventing melanoma recurrence in a large clinical study, paving the way for personalized cancer treatments. (translated)
Moderna announced positive results in the phase 3 clinical trials of its mRNA therapeutic vaccine against skin cancer, in collaboration with Merck, which significantly improves relapse-free survival in patients with advanced melanoma compared to standard treatment. (translated)
Un vaccin experimental împotriva cancerului pancreatic, denumit mKRAS-VAX, a arătat rezultate promițătoare în primele studii clinice pe oameni, demonstrând un răspuns imun semnificativ fără ca participanții cu risc crescut să dezvolte cancer pancreatic în perioada de monitorizare. #vaccinantiCancer #cancerPancreatic #rezultatePromițătoare
